ObjectiveTo determine the existence of cross-reactions between Leishmania serology and mycobacteriosis in patients infected with HIV-1.Patients and methodsHIV-positive individuals, with culture-proven episodes of tuberculosis or disseminated Mycobacterium avium complex (MAC) infection, were identified from the data files of our microbiology laboratory. Patients were included if leishmania serology had been performed within a period of 2 months before and 1 month after the diagnosis of mycobacterial disease.ResultsWe identified 106 cases of tuberculosis and 38 of disseminated MAC infection with concomitant leishmania serology in HIV-infected individuals. Among them, only two cases (1.8%), both with tuberculosis and without visceral leishmani...
We present a unique case of disseminated Leishmaniasis in an HIV patient. Two different Leishmania s...
International audienceThis review emphasises the particular difficulties encountered in confirming a...
Visceral leishmaniasis (VL) has emerged as a clinically important opportunistic infection in HIV-pos...
ObjectiveTo determine the existence of cross-reactions between Leishmania serology and mycobacterios...
Concomitant infection with human immunodeficiency virus (HIV) and the Leishmania parasite is a growi...
INTRODUCTION: In Brazil there is a large area of overlap of visceral leishmaniasis (VL) and HIV infe...
Visceral leishmaniasis is an opportunistic disease in HIV-1 infected individuals, unrecognized as a ...
Leishmaniasis is a parasitic disease affecting both animals and humans, acquired with the bite of sa...
Visceral leishmaniasis is an opportunistic disease in HIV-1 infected individuals, unrecognized as a ...
Introduction: Visceral Leishmaniasis is the most severe form of disease caused by the Leishmania don...
Leishmania-HIV co-infection has been globally controlled in Southern Europe since 1997 because of hi...
Co-infection with HIV and visceral leishmaniasis is an important consideration in treatment of eithe...
Background: Leishmania Donovani (L. donovani) is an obligate intracellular pathogen. L. donovani and...
BACKGROUND: Visceral leishmaniasis (VL) is an emerging condition affecting HIV-infected patients liv...
BACKGROUND: Human visceral leishmaniasis (VL), a potentially fatal disease, has emerged as an impor...
We present a unique case of disseminated Leishmaniasis in an HIV patient. Two different Leishmania s...
International audienceThis review emphasises the particular difficulties encountered in confirming a...
Visceral leishmaniasis (VL) has emerged as a clinically important opportunistic infection in HIV-pos...
ObjectiveTo determine the existence of cross-reactions between Leishmania serology and mycobacterios...
Concomitant infection with human immunodeficiency virus (HIV) and the Leishmania parasite is a growi...
INTRODUCTION: In Brazil there is a large area of overlap of visceral leishmaniasis (VL) and HIV infe...
Visceral leishmaniasis is an opportunistic disease in HIV-1 infected individuals, unrecognized as a ...
Leishmaniasis is a parasitic disease affecting both animals and humans, acquired with the bite of sa...
Visceral leishmaniasis is an opportunistic disease in HIV-1 infected individuals, unrecognized as a ...
Introduction: Visceral Leishmaniasis is the most severe form of disease caused by the Leishmania don...
Leishmania-HIV co-infection has been globally controlled in Southern Europe since 1997 because of hi...
Co-infection with HIV and visceral leishmaniasis is an important consideration in treatment of eithe...
Background: Leishmania Donovani (L. donovani) is an obligate intracellular pathogen. L. donovani and...
BACKGROUND: Visceral leishmaniasis (VL) is an emerging condition affecting HIV-infected patients liv...
BACKGROUND: Human visceral leishmaniasis (VL), a potentially fatal disease, has emerged as an impor...
We present a unique case of disseminated Leishmaniasis in an HIV patient. Two different Leishmania s...
International audienceThis review emphasises the particular difficulties encountered in confirming a...
Visceral leishmaniasis (VL) has emerged as a clinically important opportunistic infection in HIV-pos...